The following is a summary of “Arrhythmogenic Right Ventricular Cardiomyopathy: the importance of biventricular strain in ...

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

Although cardiomyopathy might sound like a shorthand synonym for cardiovascular disease, there are important distinctions you should know about if you or a loved one is experiencing any issues ...

Brianna Harris-Henderson started the nonprofit 'Let's Talk PPCM' to bring awareness to Peripartum Cardiomyopathy, a rare ...

Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...

Less than two months after scoring what analysts deemed a "best-case" FDA approval for its cardiomyopathy drug Attruby, California’s BridgeBio is stepping into the spotlight of the J.P. Morgan ...

The following is a summary of “Role of glucocorticoid receptor expression in Chronic Chagas Cardiomyopathy: implications for ...

In a new study, non-sonographers to use UltraSightTM Real-Time Guidance for patients that require echocardiogram By applying the p ...

A disrupted protein degradation process in heart muscle cells can lead to a range of severe heart diseases. In the case of ...

A new study has identified an enzyme that plays an important role in breaking down unneeded or damaged proteins in the heart – an important process for maintaining heart health.